Literature DB >> 29593848

Saturated fatty acids bound to albumin enhance osteopontin expression and cleavage in renal proximal tubular cells.

Alyssa Cobbs1, Kristopher Ballou1, Xiaoming Chen1, Jasmine George1, Xueying Zhao1.   

Abstract

Osteopontin (OPN) is one of the proinflammatory cytokines upregulated in the kidneys of diabetic animals and patients with nephropathy. An increase in urinary albumin and albumin-bound fatty acids (FA) presents a proinflammatory environment to the proximal tubules in proteinuric kidney diseases including diabetic nephropathy. This study was designed to examine if FA overload could stimulate OPN expression and cleavage in renal tubule epithelial cells. OPN gene and protein expression was examined in the kidney of Zucker diabetic (ZD) rats and cultured proximal tubular cells exposed to either bovine serum albumin (BSA) or BSA conjugated with palmitic acid (PA), the most abundant saturated plasma FA. Real-time PCR analysis confirmed an upregulation of renal cortical OPN gene correlated with albuminuria and nephropathy progression in ZD rats at the age of 7-20 weeks. Immunofluorescence staining of kidney sections revealed a massive induction of OPN protein in albumin-overloaded proximal tubules of ZD rats. A significant increase in both intact and cleaved OPN proteins was further demonstrated in the diabetic kidney and urine samples, which was attenuated by antiproteinuric treatment with losartan, an angiotensin II receptor blocker. When exposed to fatty acid-free BSA, NRK-52E cells exhibited an increase in protein levels of full-length and cleaved OPN. Moreover, the increase in OPN fragments was greatly enhanced in the presence of PA (250-500 µM). Together, our results support a stimulatory effect of albumin and conjugated FA on OPN expression and cleavage in renal tubule epithelial cells. Thus, besides lowering albuminuria/proteinuria, mitigating circulating FAs may be an effective intervention for preventing and slowing down the progression of nephropathy associated with obesity and type 2 diabetes.

Entities:  

Keywords:  Albuminuria; diabetic kidney disease; lipotoxicity; palmitic acid; tubular cell

Year:  2018        PMID: 29593848      PMCID: PMC5871627     

Source DB:  PubMed          Journal:  Int J Physiol Pathophysiol Pharmacol        ISSN: 1944-8171


  48 in total

1.  Osteopontin, a novel substrate for matrix metalloproteinase-3 (stromelysin-1) and matrix metalloproteinase-7 (matrilysin).

Authors:  R Agnihotri; H C Crawford; H Haro; L M Matrisian; M C Havrda; L Liaw
Journal:  J Biol Chem       Date:  2001-05-25       Impact factor: 5.157

2.  Glomerular expression of kidney injury molecule-1 and podocytopenia in diabetic glomerulopathy.

Authors:  Xueying Zhao; Yuanyuan Zhang; Lingyun Li; David Mann; John D Imig; Nerimiah Emmett; Gary Gibbons; Li-Ming Jin
Journal:  Am J Nephrol       Date:  2011-08-04       Impact factor: 3.754

3.  Protein kinase Cbeta inhibition attenuates osteopontin expression, macrophage recruitment, and tubulointerstitial injury in advanced experimental diabetic nephropathy.

Authors:  Darren J Kelly; Anna Chanty; Renae M Gow; Yuan Zhang; Richard E Gilbert
Journal:  J Am Soc Nephrol       Date:  2005-04-20       Impact factor: 10.121

4.  Cutting edge: IL-1beta mediates the proangiogenic activity of osteopontin-activated human monocytes.

Authors:  Antonella Naldini; Daria Leali; Annalisa Pucci; Emilia Morena; Fabio Carraro; Beatrice Nico; Domenico Ribatti; Marco Presta
Journal:  J Immunol       Date:  2006-10-01       Impact factor: 5.422

5.  Locations of the three primary binding sites for long-chain fatty acids on bovine serum albumin.

Authors:  J A Hamilton; S Era; S P Bhamidipati; R G Reed
Journal:  Proc Natl Acad Sci U S A       Date:  1991-03-15       Impact factor: 11.205

6.  Development of atherosclerosis in osteopontin transgenic mice.

Authors:  Satoru Chiba; Hiroshi Okamoto; Shigeyuki Kon; Chiemi Kimura; Masaaki Murakami; Manabu Inobe; Yutaka Matsui; Takeshi Sugawara; Toshihiro Shimizu; Toshimitsu Uede; Akira Kitabatake
Journal:  Heart Vessels       Date:  2002-03       Impact factor: 2.037

Review 7.  Osteopontin: a protein with diverse functions.

Authors:  D T Denhardt; X Guo
Journal:  FASEB J       Date:  1993-12       Impact factor: 5.191

8.  Osteopontin induces airway remodeling and lung fibroblast activation in a murine model of asthma.

Authors:  Martin Kohan; Raphael Breuer; Neville Berkman
Journal:  Am J Respir Cell Mol Biol       Date:  2009-01-16       Impact factor: 6.914

9.  Osteopontin plays a critical role in interstitial fibrosis but not glomerular sclerosis in diabetic nephropathy.

Authors:  Tomoaki Nagao; Takafumi Okura; Jun Irita; Masanori Jotoku; Daijiro Enomoto; Veena Rasika Desilva; Ken-Ichi Miyoshi; Mie Kurata; Yutaka Matsui; Toshimitsu Uede; Jitsuo Higaki
Journal:  Nephron Extra       Date:  2012-03-29

10.  BODIPY 493/503 Staining of Neutral Lipid Droplets for Microscopy and Quantification by Flow Cytometry.

Authors:  Bo Qiu; M Celeste Simon
Journal:  Bio Protoc       Date:  2016-09-05
View more
  5 in total

1.  Urine Metabolomics Analysis in Patients With Normoalbuminuric Diabetic Kidney Disease.

Authors:  Qian Feng; Yuanmeng Li; Yuwei Yang; Jiafu Feng
Journal:  Front Physiol       Date:  2020-10-06       Impact factor: 4.566

2.  Osteopontin Expression in Cardiomyocytes Is Increased in Pediatric Patients With Sepsis or Pneumonia.

Authors:  Camila Iansen Irion; Kiera Parrish; Krista John-Williams; Sakir H Gultekin; Lina A Shehadeh
Journal:  Front Physiol       Date:  2018-12-10       Impact factor: 4.566

3.  In situ Metabolomics of Metabolic Reprogramming Involved in a Mouse Model of Type 2 Diabetic Kidney Disease.

Authors:  Bai Linnan; Wang Yanzhe; Zhang Ling; Liu Yuyuan; Chen Sijia; Xie Xinmiao; Li Fengqin; Wang Xiaoxia
Journal:  Front Physiol       Date:  2021-11-30       Impact factor: 4.566

4.  Kidney Injury Molecule-1 Is Upregulated in Renal Lipotoxicity and Mediates Palmitate-Induced Tubular Cell Injury and Inflammatory Response.

Authors:  Xueying Zhao; Xiaoming Chen; Yuanyuan Zhang; Jasmine George; Alyssa Cobbs; Guoshen Wang; Lingyun Li; Nerimiah Emmett
Journal:  Int J Mol Sci       Date:  2019-07-11       Impact factor: 5.923

5.  OPN promotes the aggressiveness of non-small-cell lung cancer cells through the activation of the RON tyrosine kinase.

Authors:  Chengcheng Hao; Yuxin Cui; Siyuan Chang; Jing Huang; Emily Birkin; Mu Hu; Xiuyi Zhi; Wenbin Li; Lijian Zhang; Shan Cheng; Wen G Jiang
Journal:  Sci Rep       Date:  2019-12-02       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.